Former WHO Official Dr. Jeremy Farrar Joins PATH to Lead Regional Operations
Based in Geneva, Farrar will oversee operations connecting governments, research institutes, and medical manufacturers to accelerate health technology delivery across low-resource settings.
Leadership Transition and Regional Strategy at PATH
Farrar’s arrival at PATH follows his departure from the WHO, where he officially steps down on September 30, 2024. While official statements and an internal communication from WHO Director-General Dr. Tedros Adhanom Ghebreyesus described the exit as a routine retirement upon reaching the official UN retirement age limit, several sources characterized the exit as unusual, suggesting a resignation, according to reporting by Health Policy Watch and Devex.
Operating on an annual budget of over $371 million in 2024, Seattle-headquartered PATH employs approximately 1,600 people across more than 70 countries. The non-profit is funded primarily by philanthropic foundations and public government grants to advance vaccines, diagnostics, and primary healthcare innovations. Farrar’s future division managed $35.99 million in regional program expenses in 2024, according to PATH’s financial summary. His appointment directly aligns with PATH’s Strategy 2030, which focuses on bridging the gap between scientific innovation and real-world impact by strengthening primary healthcare systems.
Connecting Global Health Expertise with Local Primary Care
The appointment marks a return to regional roots for Farrar, who directed the Oxford University Clinical Research Unit in Vietnam from 1996 to 2013 before spending a decade heading the UK-based Wellcome Trust. He joined the WHO in 2023 as Chief Scientist before taking on his position as Assistant Director-General for Health Promotion, Disease Prevention and Care. That reorganization at the UN agency followed the United States withdrawing from the organization, which triggered a budget crisis.
Earlier in 2024, Farrar was mooted as a possible successor to Tedros, whose term ends in 2025. However, Farrar later told colleagues and media that he was not interested in competing for the post, which would have required a formal government nomination. Four candidates have since declared their candidacies, nominated by Saudi Arabia, Qatar, Belgium, and Indonesia.
PATH President and CEO Nikolaj Gilbert welcomed the appointment, noting that Farrar’s leadership will strengthen the organization’s ability to work with governments and partners to deliver lasting health impact. “Dr. Farrar joins PATH at a time when countries are increasingly seeking sustainable ways to expand access to health services and innovations,” PATH explained in a public statement. Addressing regional health challenges requires connecting scientific innovation directly with local primary healthcare systems to fortify outbreak preparedness.
Looking Ahead at Global Health Shifts
Establishing sustainable health security across Asia, the Middle East, and Europe will depend heavily on translating scientific breakthroughs into accessible tools for underserved communities.
